ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

SCTL Societal CDMO Inc

1.10
0.00 (0.00%)
시간외 거래
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Societal CDMO Inc SCTL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.10 09:00:00
개장가 저가 고가 종가 전일 종가
1.10 1.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202405:05GLOBECoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
08/04/202423:10BWCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
12/03/202406:04EDGAR2Form SC 14D9 - Solicitation, recommendation statements
12/03/202405:05EDGAR2Form SC TO-T - Tender offer statement by Third Party
07/03/202407:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
01/03/202407:18EDGAR2Form SC14D9C - Written communication relating to third party..
29/02/202407:27EDGAR2Form SC14D9C - Written communication relating to third party..
29/02/202407:18EDGAR2Form SC14D9C - Written communication relating to third party..
29/02/202406:58EDGAR2Form 8-K - Current report
29/02/202406:29GLOBESocietal CDMO Enters Into Definitive Agreement to be..
01/02/202421:00GLOBESocietal CDMO and Benuvia Sign Co-Marketing Agreement..
06/01/202406:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
29/11/202306:14EDGAR2Form 8-K - Current report
09/11/202306:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:11EDGAR2Form 8-K - Current report
09/11/202306:05GLOBESocietal CDMO Reports Third Quarter 2023 Financial Results
02/11/202305:05GLOBESocietal CDMO to Report Financial Results for Third Quarter..
06/10/202305:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
26/09/202305:05GLOBESocietal CDMO to Participate in RBC Capital Markets Virtual..
21/09/202305:10EDGAR2Form 8-K - Current report
21/09/202305:05GLOBESocietal CDMO Announces Corporate Restructuring
07/09/202320:00GLOBESocietal CDMO Secures Project Expansion Agreements With..
29/08/202320:00GLOBESocietal CDMO Announces Closing of $8.3 Million Public..
29/08/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/08/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202305:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202305:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/08/202305:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/08/202320:30GLOBESocietal CDMO Announces Pricing of $8.3 Million Public..
24/08/202305:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/08/202305:13EDGAR2Form 8-K - Current report
24/08/202305:04GLOBESocietal CDMO Announces Appointment of Matt Arens to Board..
24/08/202305:04GLOBESocietal CDMO Announces Proposed Public Offering of Common..
15/08/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/202305:28EDGAR2Form 8-K - Current report
15/08/202305:05GLOBESocietal CDMO Reports Second Quarter 2023 Financial Results
09/08/202320:00GLOBESocietal CDMO Reschedules Second Quarter 2023 Financial..
08/08/202304:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/08/202305:05GLOBESocietal CDMO to Report Financial Results for Second Quarter..
26/07/202320:00GLOBESocietal CDMO Announces Expansion of Controlled Substance..
10/07/202320:00GLOBESocietal CDMO Selected by Spinnaker Biosciences to Provide..
08/07/202305:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
29/06/202320:00GLOBESocietal CDMO Signs Master Service Agreement With..
23/05/202320:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
11/05/202305:05GLOBESocietal CDMO Reports First Quarter 2023 Financial Results
10/05/202305:05GLOBESocietal CDMO to Participate in RBC Capital Markets Global..
08/05/202320:00GLOBESocietal CDMO Selected by Xequel Bio to Provide CDMO..

최근 히스토리

Delayed Upgrade Clock